Birdwatch Note Rating
2023-06-14 04:52:32 UTC - HELPFUL
Rated by Participant: 302DBDAE6133B75ED718F8BEB203DB7558EBA8FB0E045A675B65C872F5C5D5ED
Participant Details
Original Note:
AstraZeneca's therapy showed 74.5% reduction in incidence of lower respiratory tract infections that require medical care. One to two out of every 100 babies below six months of age with RSV infection may need to be hospitalized. No deaths were related to the therapy https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flag-no-new-safety-issues-sanofi-astrazenecas-preventive-rsv-2023-06-06/
All Note Details